PeptiDream 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BHV-1100 / PeptiDream, Biohaven
NCT04634435: Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Recruiting
1
25
US
BHV-1100 plus cytokine induced memory-like (CIML) NK cells plus IVIG and low dose IL-2
Biohaven Pharmaceuticals, Inc., Dana-Farber Cancer Institute
Multiple Myeloma
12/24
12/24
Lu 177 PSMA I&T / Curium
CURLu177PSM0001, NCT05204927: 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
439
Europe, US
177Lu-PSMA-I&T, Abiraterone with Prednisone or Enzalutamide
Curium US LLC
Metastasis From Malignant Tumor of Prostate
08/24
02/29
PD-L1 inhibitor millamolecule / BMS
No trials found
KP0832 / Biohaven, PeptiDream
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BHV-1100 / PeptiDream, Biohaven
NCT04634435: Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Recruiting
1
25
US
BHV-1100 plus cytokine induced memory-like (CIML) NK cells plus IVIG and low dose IL-2
Biohaven Pharmaceuticals, Inc., Dana-Farber Cancer Institute
Multiple Myeloma
12/24
12/24
Lu 177 PSMA I&T / Curium
CURLu177PSM0001, NCT05204927: 177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
439
Europe, US
177Lu-PSMA-I&T, Abiraterone with Prednisone or Enzalutamide
Curium US LLC
Metastasis From Malignant Tumor of Prostate
08/24
02/29
PD-L1 inhibitor millamolecule / BMS
No trials found
KP0832 / Biohaven, PeptiDream
No trials found

Download Options